Home›Companies›Healthcare›XII Medical

XII Medical, Inc.

Updated Oct 27, 2026·Latest SEC filing Aug 30, 2024·Suggest an edit

About XII Medical

XII Medical is a private company based in Union City, California. It has reported $45,099,996 raised in three offerings on Form D since January 2021. Its chief executive is Garrett Schwab.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Aug 20, 2024Aug 30, 2024$22,500,001of $45.0M target11$2.0MEquityRule 506(b)Form D ↗
Apr 14, 2022Apr 29, 2022$7,499,999of $14.9M target7$1.0MEquityRule 506(b)Form D ↗
Dec 23, 2020Jan 7, 2021amended Apr 29, 2022$15,099,996fully sold12$1.2MEquityRule 506(b)Form D/A ↗1 earlier filing
Total, three offerings$45,099,996

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on XII Medical's Form D filed Aug 30, 2024.

GS
Garrett Schwab
Chief Executive Officer and director
DR
Duke Rohlen
Director
JF
Jd Friedland
Director
SK
Shane Kreidel
Secretary and Chief Financial Officer
RG
Raman Gowri
Director
TN
Tony Natale
Director
DG
Daniel Gottlieb
Director
Also a director at Cardiosense.

Earlier filings also listed Zachary Eisen (director, last listed Apr 2022) and Aftab Kherani (director, last listed Apr 2022).

Sources

  1. SECXII Medical, Inc. Form D, filed Jan 7, 2021
  2. SECXII Medical, Inc. filing history